Biofortuna announces significant expansion of its infrastructure and head count

Share on

Due to an increased demand of its freeze-dried molecular diagnostic kits and contract development and production service, Biofortuna has taken on an additional building, a state of the art freeze-dryer and increased its head count by 20%.

The additional space allows the creation of a dedicated Production Facility and with a separate building for Quality Control, R&D and Sales & Marketing.

The ISO certified Production Facility now houses the new state of the art freeze-dryer in a climate controlled room allowing an increased production capacity as well as a more controlled environment.

To learn more, please click here.